In the latest trading session, Pfizer (PFE) closed at $26.56, marking a -0.67% move from the previous day. The stock's performance was behind the S&P 500's daily loss of 0.04%. Elsewhere, the Dow saw ...

Big plans are in the works for the borough of Wigan in 2025. A Hilton hotel, an entertainment hub and a modern civic centre ...

Pfizer trades at a 21.7% discount to peers on a 1-yr forward P/E basis, which is a point for the bullish arguments. Find out ...

We recently compiled a list of the 13 Best Dividend Stocks to Buy Under $50. In this article, we are going to take a look at ...

Pfizer yields 6.53% and trades at 9x earnings, while Altria offers 7.58% at 10.1x earnings. Pfizer's troubling 221% payout ...

Pfizer(NYSE: PFE) is a more familiar name than it was a few years ago, before people started lining up to receive Pfizer vaccines for COVID-19. But demand for vaccines has waned now, which has taken ...

To remember Janesville native Tim Cullen is to remember what he did for his beloved Janesville and the state of Wisconsin.

Judge Katharine H Parker, handling Luigi Mangione's pre-trial hearings, is married to a former Pfizer executive and holds ...

Pfizer's oncology promises are several years from being actualized. Read why investors shouldn't assume that a sustained ...

Enanta Pharmaceuticals plans to appeal a court decision that Pfizer's Covid-19 antiviral drug, Paxlovid, doesn't infringe on its own patents. The U.S. District Court of Massachusetts ruled that Pfizer ...

The vast majority of PfE and ECR MEPs voted against this pro-abortion point, including the Spanish MEPs from Vox (PfE).

Goldman Sachs analyst maintains Buy rating on Pfizer with $33 price target. Discusses update on 2nd-gen C. diff vaccine in ...